chrisvoncsefalvay/vaers-outcomes huggingface dataset:
feeling very cold; Chills; fever; severe headache; This is a spontaneous report from a contactable consumer or other non hcp. A 26-years-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EL3247), dose 2 via an unspecified route of administration in left arm on 09Feb2021 02:45 (at 26-years age) as single dose for COVID-19 immunisation. Medical history included arthritis. Concomitant medication(s) included meloxicam (MELOXICAM) ;amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL). The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. Previously he received first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EL3247), dose 1 via an unspecified route of administration in left arm on 19Jan2021 02:45 as single dose for COVID-19 immunisation. He received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on 09Feb2021. The patient experienced chills and feeling very cold last night and this morning severe headache and fever on 10Feb2021 12:00. Patient not tested for COVID-19 after the vaccination. No treatment received for reported adverse event. The outcome of the events was not resolved.  No follow-up attempts possible. No further information expected.
joint pain; all over aches snd pains in my muscles; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (joint pain) and MYALGIA (all over aches snd pains in my muscles) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (joint pain) and MYALGIA (all over aches snd pains in my muscles). At the time of the report, ARTHRALGIA (joint pain) and MYALGIA (all over aches snd pains in my muscles) outcome was unknown.            No concomitant medications reported. No treatment information was provided.
After the shot i got the shingle / Suspected vaccination failure; Got the shingle; Shingles can be debilitating; Took me to hospital because of pain; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, weakness and pain. On an unknown date, the outcome of the vaccination failure, shingles, weakness and pain were unknown.   It was unknown if the reporter considered the vaccination failure, shingles, weakness and pain to be related to Shingles vaccine.  Additional case details were reported as follows: The reporter was patient itself. The age at vaccination was not reported. The patient stated that shingles could be debilitating, after she got the shingle shot she got the shingle. Her husband and daughter took her to a hospital as she was such in pain they did not do nothing not even advice for a calamine lotion. This case was considered as suspected vaccination failure, as details regarding completion of primary vaccination schedule, laboratory test confirmation and time to onset for shingles were unknown at the time of reporting. The follow up was not required.
Light-headedness followed by vertigo, then nausea, then vomiting beginning around 11:00 p.m. Took Dramamine around 7:00 a.m. Slept until almost noon, by which time nausea had subsided substantially. Vertigo continues (3:30 p.m.).
13h after second dose: intense vertigo which improved following day but still present  for 8 days
Patient noticed hives approx. 20 min post injection. Hives were itchy with an oozing center, remained itchy/oozing approximately 1 wk no previous reaction to annual seasonal influenza vaccinations. Vaccine administrator told me to report this event myself.
Patient was given the pediatric Pfizer covid vaccines rather than the adult dose.  Patient did not experience any adverse effects.  Per call with Pfizer, per the CDC the patient only needs to get the adult dose for the second dose at the normal 21 day interval.
Information has been received from a health professional concerning an 18 year old white female with asthma who on 03-SEP-2007 was vaccinated with her third dose of GARDASIL intramuscularly in the left deltoid at 12:00. Within 15 minutes of the vaccine the patient felt nauseous followed by a feeling like an asthma attack was occurring. The patient tried her inhaler but it did not help. She collapsed in her dorm room. Emergency services were called and the patient was given oxygen. The medics inserted an IV but never used. The patient complained of feeling numb and the medics helped to unclench her hands and feet. She was taken to the emergency room at a hospital where the symptoms subsided. The patient checked herself out after 2 hours in the emergency room. The patient denied receiving any medication. The patient developed a serious sinus infection and felt weak for 2-3 days after the vaccine. The patient did not use her inhaler the first two times. The patient's first GARDASIL vaccination was on 27-FEB-2007 and her second dose was on 27-APR-2007. Additional information has been requested. This is in follow-up report(s) previously submitted on 1/15/2008. The patient's first GARDASIL vaccination was on 27-FEB-2007 and her second dose was on 27-APR-2007. Follow up information was received on 21-FEB-2008 and it was reported that the patient is presently doing well. No other information is expected.
I had back pain two days after I got Johnson & Johnson shot. Then, 5 days later, my skin started to peel off from my hands...I'm checking my hands everyday and they are getting worse.
heart dysrhythmia; period of palpitations; This is a spontaneous report from a contactable nurse (reporting for himself). A 46-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot/ batch number: EL3246, expiry date unknown), via an unspecified route of administration in the right arm on 05Jan2021, 10:30AM (at 46 years old),  at single dose for COVID-19 immunization. The patient's medical history included high cholesterol (treated with statin medications) and seasonal allergies, both from an unknown date and unknown if ongoing. Concomitant medications included atorvastatin, ashwagandha, and ergocalciferol (VIT D). At 46 years old, the patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot/ batch number and expiry date unknown), via an unspecified route of administration in the left arm on 15Dec2020, 10:00AM at single dose for COVID-19 immunization. The patient has not received other vaccine in four weeks prior to vaccination. Patient did not have COVID prior to vaccination and has not tested for COVID after vaccination. In the morning of 07Jan2021 (approximately 9 am), the patient experienced a period of palpitations, and heart dysrhythmia lasting for approximately 1 hour. The episode resolved on its own and has not returned. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events; patient had echocardiogram, EKG, and 7 days heart monitoring from an unspecified date. The patient recovered from "heart dysrhythmia" on 07Jan2021, 10:00AM, and recovered from a period of palpitations an unspecified date.  Information on lot/batch number (first dose) has been requested.; Sender's Comments: Based on the available information, a causal relationship between event heart dysrhythmia and BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) cannot be excluded.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
A SORE THROAT; GLANDS ON HER NECK WERE MORE SWOLLEN; TIRED; SOME TENDERNESS ON THE SITE OF INJECTION FOR A COUPLE OF DAYS; This spontaneous report received from a patient concerned a 68 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included hypothyroidism, lupus, connective tissue disease, penicillin allergy, and sulfonamide allergy. The patient experienced drug allergy when treated with cefalexin. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1005018, and batch number: 1005018 expiry: UNKNOWN) dose was not reported, 1 total, administered on 16-MAR-2021 for prophylactic vaccination. Concomitant medications included methotrexate. On 16-MAR-2021, the subject experienced some tenderness on the site of injection for a couple of days. On 20-MAR-2021, the subject experienced a sore throat. On 20-MAR-2021, the subject experienced glands on her neck were more swollen. On 20-MAR-2021, the subject experienced tired. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from some tenderness on the site of injection for a couple of days on 18-MAR-2021, and had not recovered from a sore throat, glands on her neck were more swollen, and tired. This report was non-serious.
Suddenly became light headed and fainted/passed out around 10:30 am on Saturday, April 24, 2021.  Around 3:00 am, slight chills treated and resolved with Tylenol. No further chills.  Arm soreness moderate day after injection, mild two days later.
SUSPECTED COVID-19 INFECTION; SUSPECTED CLINICAL VACCINATION FAILURE; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age, sex, race and ethnic origin. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 207A21A, expiry: unknown) frequency 1 total, dose, start therapy date were not reported for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the patient felt like flu instead of pneumonia (suspected covid-19 infection). On an unspecified date in DEC-2021, the patient tested positive for coronavirus disease-19 (COVID-19) (suspected clinical vaccination failure). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the suspected covid-19 infection and suspected clinical vaccination failure was not reported. This report was serious (Other Medically Important Condition). This report was associated with product quality complaint: 90000214935. This case, from the same reporter is linked to 20220200531.; Sender's Comments: V0: 20220200721-COVID-19 VACCINE AD26.COV2.S-suspected clinical vaccination failure. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS
On 2/29/00, the mother phones reporting that the child had complained of feeling wound up inside and had been having problems with school work since he had Hep B vax. When questioned regarding allergies, she reported that she had a 3 page sheet of allergies  and at the time did not related yeast to the term candidiasis albicans which he had tested positive to upon allergy testing.
Patient had no issues with the first injection. States she felt like her face was burning, she was having trouble breathing, and felt light headed. Denies any prior anaphylactic reactions, denies vagal experiences after blood draws. Symptoms started within 5 minutes of the vaccination. Vistaril given, patient monitored for one hour in the emergency department with no further incident and returned to work,.
Severe cramping in legs -  can?t walk Severe cramping in arms and hands Uncomfortable burning in feet and legs Weakness  May be reacting to antibiotics for bladder. Currently stopping antibiotics. Directions from doctor  Please help should I take #2 shot
Got COVID shot March 3, then had some alteration of taste around March 8 or so, then L facial paralysis consistent w Bell Palsy on March 11.
5 minutes after vaccination given patient lost consciousness and then vomited. She came to and then again lost consciousness. Epi-pen was administered and patient regained consciousness but was not able to talk. EMS was called and took her to hospital.
soreness in the arm where it was injected; last a couple of days; mild headache; lasted about 8 hours or so; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness in the arm where it was injected; last a couple of days) and HEADACHE (mild headache; lasted about 8 hours or so) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included SALBUTAMOL (VENTOLIN ES) for COPD, COLECALCIFEROL (VITAMIIN D PAIKESE) for an unknown indication.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, the patient experienced PAIN IN EXTREMITY (soreness in the arm where it was injected; last a couple of days) and HEADACHE (mild headache; lasted about 8 hours or so). On 30-Mar-2021, HEADACHE (mild headache; lasted about 8 hours or so) had resolved. On 31-Mar-2021, PAIN IN EXTREMITY (soreness in the arm where it was injected; last a couple of days) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient took Tylenol to relieve the symptoms.   This case was linked to MOD-2021-096269 (Patient Link).
ALLERGIC REACTION, INIT 7/8/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Information has been received from a physician concerning a female patient who on 05-DEC-2008 was vaccinated with a 0.65ml dose of ZOSTAVAX (Oka/Merck) (lot # not provided).  On 12-DEC-2008 the patient experienced rash on her wrist on the arm she was vaccinated.  The patient was diagnosed with shingles and was prescribed VALTREX.  Additional information has been requested.
Vaccine was given incorrect route. Patient was brought back for correct vaccine and correct route on 10/26/2022
Arm was in instant pain. Arm is still achy over three weeks later. Hurts to lift arm above head. Hurts to turn steering wheel. Hurts to take off and put on clothes. Hurts to bear any weight- even my own arm weight at times.
Extreme fatigue, body aches, MS like symptoms, muscle pain, headaches, dizziness, continued illness.
lt deltoid erythema 2 phases central erythema 3x4";peripheral erythema less intense 4x8";it edematous & warm full rang of motion w/o pain;
COVID 19 Treatment/Severe chest congestion, throat irritation, heavy head, headache, sleepy, ears ringing sometimes, light fever 37,.1C, fatigue, willing to cough; COVID 19 Treatment/Severe chest congestion, throat irritation, heavy head, headache, sleepy, ears ringing sometimes, light fever 37,.1C, fatigue, willing to cough; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An adult female patient (not pregnant) received bnt162b2 (BNT162B2), on 03Dec2021 as dose 3 (booster), single (Lot number: FJ1420) for covid-19 immunisation; covid-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "High blood pressure" (unspecified if ongoing); "high cholesterol" (unspecified if ongoing); "obesity" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 06Oct2023, outcome "recovered" (12Oct2023) and all described as "COVID 19 Treatment/Severe chest congestion, throat irritation, heavy head, headache, sleepy, ears ringing sometimes, light fever 37,.1C, fatigue, willing to cough". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (06Oct2023) Positive; (12Oct2023) negative; (13Oct2023) negative. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: Patient received Paxlovid treatment from 06Oct2023 to 11Oct2023. Patient got COVID on 06Oct2023 for the first time. She was 3 times vaccinated before. After started taking Paxlovid, recovered extremely fast. No initial symptoms: Severe chest congestion, throat irritation, heavy head, headache, sleepy, ears ringing sometimes, light fever 37.1 C, fatigue, willing to cough. She was negative on 12Oct-13Oct and on 14Oct she was positive again Rebound.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300329594 same patient, different drug and different event;
MOM CALLED CLINIC APPROX 6 HRS AFTER VACCINES WERE GIVEN. STATED PATIENT HAD A RASH ON LEGS, GROIN, AND STOMACH. DENIED FEVER AND STATED RASH DID NOT SEEM TO BOTHER (ITCH) PATIENT. STATED SHE WOULD F/U WITH PCP IF RASH PERSISTED.
Within 45 minutes (waited at vaccination center 20 minutes); severe nausea, palms of both hands and both feet turned red and extremely itchy as in allergic reaction, tightened feeling in throat.   Took liquid and pill form of Benedryl; 2x normal dose.   Started feeling  some relief within 2 hours (was going to go to Urgent care if not responding to medicine).  On going slight itching, some hand and foot tingling for next 10 hours.  Took additional liquid Benedryl dose at 7 pm.  Injection site extremely sore 20 hours later, difficult to lift arm and site is red, hard and tender.
Swelling erythematous bruising ,blistering weeping vesicular eruptions on arm extending up and down from injection site >10cm Pain Ice,benadryl  Hydroxyzine Prednisone  Motrin
HYPOTENSION 4/17/2023 COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE)
Severe tingling in both feet, both hands, for 4 days, that spread into legs and arms on the last day before it subsided. Also had large knot and itching at site of injection for 8 days.
Extreme shaking, chills, fever, difficult getting breathe, entire body aches, temp has been between 101 and 103
little tempeture; Headache; This case was reported by a consumer via call center representative and described the occurrence of fever in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On 8th October 2020, the patient received the 1st dose of Shingrix. In October 2020, less than a week after receiving Shingrix, the patient experienced fever and headache. On an unknown date, the outcome of the fever and headache were not recovered/not resolved.   It was unknown if the reporter considered the fever and headache to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but it was selected as adult as per the vaccine indication. The patient received Shingrix and had little temperature and Headache.  The reporter asked how long these affect would last.
Constant crying, intermittent stiffening of body for 4 hrs beginning 4-5 hrs p/vax administered; Low grade fever, mild local swelling @ DTP site;
TEMPERATURE EXCURSION OCCURRED DUE TO THE PLACEMENT OF HAND WARMERS IN THE INSULATED BAG USED TO TRANSPORT VACCINE. ALL 81 PERSONS RECEIVING VACCINE IN LANES 5 AND 6 AT THE MVS ON 02/15/2021 BETWEEN 14:00 and 16:45 WERE NOTIFIED THEY  RECEIVED VACCINE THAT WAS OUTSIDE OF THE APPROPRIATE TEMPERATURE RANGE AND WERE RECOMMENDED TO BE REVACCINATED.
Felt sick; This is a spontaneous report from a non-contactable nurse. A 17-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 06May2021 (at the age of 17-years-old) as a single dose for COVID-19 immunisation. It was unknown if the patient had any medical history or any known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19.  It was unknown if the patient received any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On 06May2021, the patient received 2nd dose and felt sick.  Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event felt sick was not resolved at the time of this report.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
pain; Hurts; Feel sick; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a adult female patient who received Herpes zoster (Shingrix) (batch number FG2D4, expiry date 19th September 2021) for prophylaxis.   On 10th June 2019, the patient received Shingrix. On 11th June 2019, 1 days after receiving Shingrix, the patient experienced pain in arm. In June 2019, the patient experienced pain and sickness. On an unknown date, the outcome of the pain in arm was not recovered/not resolved and the outcome of the pain and sickness were unknown.   It was unknown if the reporter considered the pain in arm, pain and sickness to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received shingrix vaccine on an unknown arm. The patient experienced pain in arm, felt sick and hurt after receiving  a dose of Shingrix.
Severe short term memory loss and speaking, no drooling or slurring. He was asking family member questions about common information about himself and others that he should know the answers. Called 911, did not remember that he called 911 and his family members insisted that he take ambulance to Hospital. He was admitted into the Intensive Care Unit 9/8/18, and discharged 9/11/18 from Hospital. Blood pressure 220/104.